ZNF701
Zinc finger protein 701
Also known as: FLJ10891, ZN701_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NV72
- Gene
- ZNF701
- Ensembl
- ENSG00000167562
- Chromosome
- 19
- Canonical length
- 531 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Centriolar satellite
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
531 residues, UniProt reviewed canonical sequence.
>Q9NV72|ZNF701
1 MGFLHVGQDG LELPTSGDPP ASASQSAGIT GVSHRTQPPC FEGLTSKDLV REEKTRKRKR
61 KAKESGMALL QGLLTFRDVA IEFSQEEWKC LDPAQRTLYR DVMLENYRNL VSLDTSSKCM
121 MKMFSSTGQG NTEVVHTGTL QIHASHHIGD TCFQEIEKDI HDFVFQWQEN ETNGHEALMT
181 KTKKLMSSTE RHDQRHAGNK PIKNELGSSF HSHLPEVHIF HPEGKIGNQV EKAINDAFSV
241 SASQRISCRP KTRISNKYRN NFLQSSLLTQ KREVHTREKS FQRNESGKAF NGSSLLKKHQ
301 IIHLGDKQYK CDVCGKDFHQ KRYLACHRCH TGENPYTCNE CGKTFSHNSA LLVHKAIHTG
361 EKPYKCNECG KVFNQQSNLA RHHRVHTGEK PYKCEECDKV FSRKSHLERH RRIHTGEKPY
421 KCKVCDKAFR RDSHLAQHTV IHTGEKPYKC NECGKTFVQN SSLVMHKVIH TGEKRYKCNE
481 CGKVFNHKSN LACHRRLHTG EKPYKCNECG KVFNRKSNLE RHHRLHTGKK SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF701 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 6.8 nTPM
Expression across tissuesHPA
Tissue
- thymus: 6.8 nTPM
- placenta: 5.8 nTPM
- thyroid gland: 5.5 nTPM
- lymph node: 5.4 nTPM
- breast: 5.3 nTPM
- bone marrow: 5.1 nTPM
Single-cell type
- syncytiotrophoblasts: 44 nCPM
- enterocytes: 33 nCPM
- distal convoluted tubule cells: 33 nCPM
- loop of henle epithelial cells: 33 nCPM
- renal collecting duct intercalated cells: 32 nCPM
- renal connecting tubule cells: 30 nCPM
Immune cell
- neutrophil: 21 nTPM
- basophil: 21 nTPM
- eosinophil: 17 nTPM
- NK-cell: 12 nTPM
- intermediate monocyte: 8.9 nTPM
- memory B-cell: 8.6 nTPM
Brain region
- white matter: 14 nTPM
- cerebellum: 12 nTPM
- basal ganglia: 12 nTPM
- pons: 10 nTPM
- choroid plexus: 10 nTPM
- thalamus: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.1
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF701 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF701 as an antibody target. Whether an autoantibody or antibody against ZNF701 could matter depends on whether native ZNF701 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF701 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF701 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...